The Asthma and COPD Market Outlook: Market analysis of future growth and leading players by sector

Executive Summary

Business Insights have teamed up with IMS Health to bring you, ’The Asthma and COPD Market Outlook: Market analysis of future growth and leading players by sector.’ This unique product offering provides an analysis of changing market conditions and strategic future outlook using the gold standard IMS Health sales data and Business Insights ’ expert analysis, an unrivalled source of pharmaceutical intelligence on the asthma and COPD market. Refresh your asthma strategy with new analysis In terms of revenue, the asthma and COPD therapeutic area historically ranks as the sixth largest single source of sales for the pharmaceutical industry. The outlook for the market is currently strong, driven by strategically sound lifecycle management from the major players in the asthma and COPD area, new product launches and favourable epidemiology. Generic competition will continue to remain the major threat to sales growth in this market. The Asthma and COPD Market Outlook: Market analysis of future growth and leading players by sector, provides detailed analysis of all classes of asthma and chronic obstructive pulmonary disease (COPD) drugs across all major indications. Forecasts are provided over the period 2004-2009,enabling you to identify the market leaders of the future and spot potential opportunities and threats to your market position.